From: Trends in guideline implementation: an updated scoping review
Target group | Outcome measures | Type of impact reported in included studies (n, %) References | Total studies (n, %) | ||
---|---|---|---|---|---|
Positive (all reported outcomes improved) | Mixed (some reported outcomes improved) | No change (no outcomes improved) | |||
Patient/family | Patient outcomes (e.g., reduced cholesterol) | --- | --- | 3, 2.5% | |
Behavior (e.g., medication adherence) | --- | 1, 0.8% [69] | 3, 2.5% | ||
Multiple outcomes | 1, 0.8% [147] | 1, 0.8% [130] | 1, 0.8% [116] | 3, 2.5% | |
Healthcare professional | Knowledge, attitudes, beliefs | 1, 0.8% [145] | 4, 3.4% | ||
Behavior (e.g., medication prescribing) | 35, 29.7% [42, 46, 48,49,50,51, 54, 55, 59, 63, 71, 80, 82, 100, 103, 108,109,110, 112, 113, 115, 119, 125, 127, 128, 132, 133, 136, 138, 140, 144, 146, 153, 154, 157] | 13, 11% [45, 53, 77, 79, 86, 94, 97, 105, 107, 124, 129, 134, 150] | 12, 10.2% [47, 58, 65, 67, 91,92,93, 96, 101, 114, 118, 151] | 60, 50.8% | |
Institutional/health system outcomes (e.g., reduced mortality or length of hospital stay) | --- | --- | 1, 0.8% [84] | 1, 0.8% | |
Multiple outcomes | 12, 10.2% [56, 61, 62, 73, 74, 117, 121, 135, 139, 148, 149, 159] | 1, 0.8% [88] | 15, 12.7% | ||
Both patient/family and healthcare professionals | Multiple outcomes | 14, 11.9% [43, 60, 64, 68, 70, 72, 85, 90, 98, 104, 111, 152, 155, 156] | 29, 24.6% | ||
Total | 66, 55.9% | 31, 26.3% | 21, 17.8% | 118, 100% |